本页面由Tiger Trade Technology Pte. Ltd.提供服务

Iterum Therapeutics Plc

0.0300
0.0000
成交量:- -
成交额:- -
市值:159.87万
市盈率:-0.04
高:0.0300
开:0.0300
低:0.0300
收:0.0300
52周最高:1.42
52周最低:0.0271
股本:5,329.16万
流通股本:5,237.58万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.7366
每股收益(LYR):-1.2576
净资产收益率:-555.68%
总资产收益率:-53.28%
市净率:-0.22
市盈率(LYR):-0.02

数据加载中...

2021/02/05

重要事件披露

8-K - Current report
2021/02/04

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/04

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

重要事件披露

8-K - Current report
2020/12/23

重要事件披露

8-K - Current report
2020/12/21

重要事件披露

8-K - Current report
2020/12/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/23

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/16

重要事件披露

8-K - Current report
2020/11/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/27

重要事件披露

8-K - Current report
2020/10/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/20

SEC问询函

CORRESP [Cover] - Correspondence